Publications by authors named "Catalin Codreanu"

Claim this Profile
C
Complementary Role of Ultrasound and Clinical Features in Assessing Carpal Tunnel Syndrome Severity: A Cross-Sectional Study.
Daniela Nicoleta Popescu, Claudiu Costinel Popescu, Oana Morari, Natalia Blidaru, Alina Dima, Catalin Codreanu

Diagnostics (Basel)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis Treated With JAK Inhibitors Compared With Biologic Disease-Modifying Antirheumatic Drugs: Data From an International Collaboration of Registries.
Romain Aymon, Denis Mongin, Romain Guemara, Zubeyir Salis, Johan Askling, Catalin Codreanu

Arthritis Rheumatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EULAR/ACR risk stratification criteria for development of rheumatoid arthritis in the risk stage of arthralgia.
Hanna W van Steenbergen, Frank Doornkamp, Stefano Alivernini, John Backlund, Catalin Codreanu

Ann Rheum Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship between lifestyle factors and outcome of treatment with TNFα inhibitors in axial spondyloarthritis - results from 14 European countries.
Gareth T Jones, Ovidiu Rotariu, Ross MacDonald, Brigitte Michelsen, Bente Glintborg, Catalin Codreanu

BMC Rheumatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of Secukinumab Treatment Response and Continuation in Axial Spondyloarthritis: Results From the EuroSpA Research Collaboration Network.
Marion Pons, Stylianos Georgiadis, Merete Lund Hetland, Zohra Faizy Ahmadzay, Simon Rasmussen, Catalin Codreanu

J Rheumatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disparities in the organisation of national healthcare systems for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe.
Brigitte Michelsen, Mikkel Østergaard, Michael John Nissen, Adrian Ciurea, Burkhard Möller, Catalin Codreanu

Health Policy· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Four-year secukinumab treatment outcomes in European real-world patients with axial spondyloarthritis and psoriatic arthritis.
Marion Pons, Stylianos Georgiadis, Mikkel Østergaard, Zohra Faizy Ahmadzay, Bente Glintborg, Catalin Codreanu

Joint Bone Spine· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EULAR/American College of Rheumatology Risk Stratification Criteria for Development of Rheumatoid Arthritis in the Risk Stage of Arthralgia.
Hanna W van Steenbergen, Frank Doornkamp, Stefano Alivernini, John Backlund, Catalin Codreanu

Arthritis Rheumatol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex differences in patient-reported outcome measures and the association with clinical factors in axial spondyloarthritis patients treated with tumour necrosis factor inhibitors.
Pasoon Hellamand, Marleen G H van de Sande, Michael T Nurmohamed, Ronald F van Vollenhoven, Rosemary J Hollick, Catalin Codreanu

Rheumatology (Oxford)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact and Prevalence of Depression and Anxiety in Rheumatoid Arthritis-A Cross-Sectional Study with Self-Reported Questionnaires.
Cătălina-Elena Ionescu, Claudiu C Popescu, Cătălin Codreanu

J Clin Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenge of missing data in observational studies: investigating cross-sectional imputation methods for assessing disease activity in axial spondyloarthritis.
Stylianos Georgiadis, Marion Pons, Simon Rasmussen, Merete Lund Hetland, Louise Linde, Catalin Codreanu

RMD Open· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in the response to TNF inhibitors at distinct joint locations in patients with psoriatic arthritis: results from nine European registries.
Adrian Ciurea, Seraphina Kissling, Andrea Götschi, Lykke Midtbøll Ørnbjerg, Simon Horskjær Rasmussen, Catalin Codreanu

Arthritis Res Ther· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing DAPSA, DAPSA28, and DAS28-CRP in Patients With Psoriatic Arthritis Initiating a First Tumor Necrosis Factor Inhibitor Across Nine European Countries.
Louise Linde, Stylianos Georgiadis, Lykke M Ørnbjerg, Simon H Rasmussen, Brigitte Michelsen, Catalin Codreanu

Arthritis Care Res (Hoboken)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recording of non-musculoskeletal manifestations, comorbidities and safety outcomes in European spondyloarthritis registries: a survey.
Zohra F Ahmadzay, Jette Heberg, Jacob B Jørgensen, Lykke M Ørnbjerg, Mikkel Østergaard, Catalin Codreanu

Rheumatol Adv Pract· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Additional Value of Ultrasound in Patients with Psoriatic Arthritis within Treatment Target.
Mihaela Agache, Claudiu C Popescu, Luminița Enache, Corina Mogoșan, Emilio Filippucci, Cătălin Codreanu

J Clin Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug effectiveness of 2nd and 3rd TNF inhibitors in psoriatic arthritis - relationship with the reason for withdrawal from the previous treatment.
Lykke Midtbøll Ørnbjerg, Cecilie Heegaard Brahe, Louise Linde, Lennart Jacobsson, Michael J Nissen, Catalin Codreanu

Joint Bone Spine· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of secukinumab in radiographic and non-radiographic axial spondyloarthritis: a European routine-care observational study.
Sara Nysom Christiansen, Simon Horskjær Rasmussen, Mikkel Ostergaard, Marion Pons, Brigitte Michelsen, Catalin Codreanu

RMD Open· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex Differences in the Effectiveness of First-Line Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis: Results From the European Spondyloarthritis Research Collaboration Network.
Pasoon Hellamand, Marleen G H van de Sande, Lykke M Ørnbjerg, Thomas Klausch, Kari K Eklund, Catalin Codreanu

Arthritis Rheumatol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care.
Lykke M Ørnbjerg, Kathrine Rugbjerg, Stylianos Georgiadis, Simon H Rasmussen, Lennart Jacobsson, Catalin Codreanu

J Rheumatol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Depression in Rheumatoid Arthritis: Prevalence and Effects on Disease Activity.
Cătălina-Elena Ionescu, Claudiu Costinel Popescu, Mihaela Agache, Georgiana Dinache, Cătălin Codreanu

J Clin Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept: Results from the international TOCERRA and PANABA observational collaborative studies.
Kim Lauper, Denis Mongin, Sytske Anne Bergstra, Denis Choquette, Catalin Codreanu

Joint Bone Spine· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the 'JAK-pot' study).
Romain Aymon, Denis Mongin, Sytske Anne Bergstra, Denis Choquette, Catalin Codreanu

Ann Rheum Dis· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Agache et al. Nail Ultrasound in Psoriasis and Psoriatic Arthritis-A Narrative Review. 2023, , 2236.
Mihaela Agache, Claudiu C Popescu, Luminita Enache, Bianca M Dumitrescu, Catalin Codreanu

Diagnostics (Basel)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From Pathogenesis to Treatment-New Perspectives in Rheumatology.
Elena Rezus, Catalin Codreanu

Int J Mol Sci· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetes mellitus as a risk factor and comorbidity in gout.
Larisa Rotaru, Liliana Groppa, Eugeniu Russu, Lia Chișlari, Cătălin Codreanu

Folia Med (Plovdiv)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis